Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment
Abstract
Share and Cite
Lee, W.-H.; Loo, C.-Y.; Traini, D.; Young, P.M. Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment. Pharmaceutics 2021, 13, 9. https://doi.org/10.3390/pharmaceutics13010009
Lee W-H, Loo C-Y, Traini D, Young PM. Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment. Pharmaceutics. 2021; 13(1):9. https://doi.org/10.3390/pharmaceutics13010009
Chicago/Turabian StyleLee, Wing-Hin, Ching-Yee Loo, Daniela Traini, and Paul M. Young. 2021. "Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment" Pharmaceutics 13, no. 1: 9. https://doi.org/10.3390/pharmaceutics13010009
APA StyleLee, W.-H., Loo, C.-Y., Traini, D., & Young, P. M. (2021). Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment. Pharmaceutics, 13(1), 9. https://doi.org/10.3390/pharmaceutics13010009